KKR Considers Acquisition of Italian Health-Care Tech Firm GPI

KKR is considering acquiring GPI SpA, an Italian healthcare technology firm with a market value of $438 million. GPI provides solutions for the healthcare sector, including hospital information systems, diagnostic solutions, and care service technologies. KKR's deliberations are ongoing, but there is no certainty of a transaction. The acquisition would be KKR's latest in a flurry of private equity buyouts in Europe this year.

KKR & Co., a prominent private equity firm, is reportedly considering the acquisition of Italian health-care technology firm GPI SpA, according to sources familiar with the matter. The potential deal comes amid recent market volatility and a surge in private equity buyouts in Europe. GPI SpA, based in Trent, provides a range of technological solutions to the healthcare sector, including hospital information systems, diagnostic solutions, and care service technologies.

The acquisition would add to KKR's string of deals in Europe this year, following its recent agreement to buy Spectris Plc for £4.1 billion. GPI SpA has seen its shares rise 24% in Milan trading this year, giving the company a market value of about €377 million ($438 million) [1].

An investment vehicle backed by GPI Chief Executive Officer Fausto Manzana holds a significant stake in the company, with a 48% ownership equivalent to 57% of the voting rights. Deliberations are ongoing, but there is no certainty that the transaction will materialize. A representative for KKR declined to comment, as did a spokesperson for GPI.

The global private equity sector saw a 7% increase in buyout deal value in 2024 compared to 2023, with Europe being the only region to record a quarter-on-quarter increase in aggregate deal value. Europe accounted for 28% of the global aggregate, with a total of $31.8 billion invested in buyout deals [3].

This acquisition would be part of a broader trend of private equity firms taking advantage of a better financing environment and cheaper valuations in Europe. KKR has been particularly active in the region, notching deals for Swedish consumer-health company Karo Healthcare and post-trade services provider OSTTRA.

References:
[1] https://www.bloomberg.com/news/articles/2025-07-16/kkr-said-to-mull-acquisition-of-health-care-technology-firm-gpi
[2] https://www.gurufocus.com/term/interest-and-commission-paid/CHIX:GPIM
[3] https://international-adviser.com/global-private-equity-sees-7-rise-in-value-of-capital-buyouts-in-2024/